About
Invicol GmbH is a MedTech start-up located in the CoLaborator of the Bayer AG in Berlin, where we are developing the BMProbe. The Probe is inserted into the patients' cubital vein for the isolation of rare circulating cells. The minimally invasive approach has a high sensitivity and specificity providing compelling and improved diagnostic value. Our technology opens new possibilities in the field of personalized medicine, early diagnosis and disease monitoring.
Technologies
Mobile FriendlyWordPress.orgNginx
Keywords
medical equipment manufacturinghealthcare equipment & suppliesblood flow screening deviceblood biomarker analysismedical device developmentpersonalized oncology diagnosticsblood sample screeningscalable coating processesnanostructured metal surfacesin vivo ctc extractionadvanced surface functionalizationmetastasis pathway analysisblood cell repellent coatingspreclinical animal studiespancreatic cancer ctc captureblood volume screeningcollaborative research projectsin vivo cell isolationmedical equipment and supplies manufacturinghealthcare technologyb2beu-funded biomedical researchpersonalized medicinemedical technologycell isolation technologybiocompatibility testingbioinspired coatingsmedical devicesbiotech innovationminimally invasive device
Company Information
- Employees2
Location
Delaware, United States
